Less commonly, GLP-1 use has been linked to more significant reactions like hives, angioedema, or immune related skin conditions
In a blog, the facility writes that MT2 isn't "currently approved by the FDA." Additionally, West Lake Dermatology says that the compound "cannot be legally marketed or sold as a drug, supplement, or cosmetic product." Further, it isn't "used in standard medical practices." It's "largely unregulated, with no reliable assurance of purity, sterility, or dosing." West Lake Dermatology writes that MT2 began its life as a peptide used for academic purposes
Exendin 939 did not affect proton-induced TRPV1 activation, suggesting its selective antagonism
That perception has changed
Use of antihyperglycemic drugs and risk of cancer in patients with diabetes
Kidney360 2 , 254262 (2021)